- Investing Ideas
- /
- South African Undervalued Stocks Based On Cash Flows
South African Undervalued Stocks Based On Cash Flows
Results
7
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
7 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GFI | R265.40 | 3.9% | -12.8% | R237.5b | R285.23 | PE19.9x | E32.1% | 2.6% | Materials | ||
MCG | R108.20 | 0.2% | 49.2% | R46.5b | R116.00 | PS0.9x | E103.4% | 0% | Media | ||
MUR New | R1.10 | 0% | 48.6% | R447.9m | n/a | PS0.03x | S6.0% | 0% | Capital Goods | ||
PPC | R4.80 | 2.6% | 30.8% | R7.3b | R4.70 | PE68.4x | E45.9% | 2.9% | Materials | ||
SUI | R43.98 | -0.09% | 8.2% | R10.8b | R63.20 | PE10.7x | E20.3% | 8.3% | Consumer Services | ||
PPH | R28.88 | 1.5% | 52.1% | R105.9b | R26.50 | PE45.5x | E31.0% | 1.7% | Retail | ||
APN | R169.12 | -0.3% | -14.1% | R75.1b | R226.82 | PE17.1x | E22.4% | 2.1% | Pharmaceuticals & Biotech |
Page 1 of 1